Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday.
美股期貨今早高開，納斯達克期貨週三上漲約50點。
Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) fell sharply in today's pre-market trading after the company posted downbeat results for its third quarter on Tuesday.
Kura Sushi USA股票（NASDAQ：KRUS）週二公佈了第三季度業績不佳的消息，今天的美國股市盤前交易中，該股票急劇下跌。
Kura Sushi reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.01. The company reported quarterly sales of $63.082 million which missed the analyst consensus estimate of $63.101 million, according to data from Benzinga Pro.
苦艾酒（Kura Sushi）報告第三季度收益每股0.00美元，低於分析師平均預期的0.01美元。根據Benzinga Pro的數據，公司第三季度銷售額爲6308.2萬美元，低於分析師平均預期的6310.1萬美元。
Indivior shares fell 4.2% to $56.00 in the pre-market trading session.
Indivior股票在美股盤前交易中下跌4.2％，跌至56.00美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盤前交易中錄得下跌的一些大型股票。
- LegalZoom.com, Inc. (NASDAQ:LZ) shares dipped 18.3% to $6.41 in pre-market trading after the company announced a CEO transition and lowered its full year guidance.
- Stardust Power Inc. (NASDAQ:SDST) declined 13.5% to $8.99 in pre-market trading after gaining around 9% on Tuesday.
- 10x Genomics, Inc. (NASDAQ:TXG) shares fell 9.8% to $16.46 in pre-market trading. On Tuesday, Goldman Sachs analyst Matthew Sykes maintained 10x Genomics with a Sell and lowered the price target from $26 to $16.
- IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 6.4% to $36.13 in pre-market trading. IDEAYA priced $263 million public offering of 228,572 common shares and pre-funded warrants at $35 per share.
- Hudson Pacific Properties, Inc. (NYSE:HPP) shares declined 4.9% to $4.90 in pre-market trading.
- uniQure N.V. (NASDAQ:QURE) slipped 4.5% to $6.37 in pre-market trading. UniQure shares jumped 76% on Tuesday after the company announced updated interim data including up to 24 months of follow-up data from 29 treated patients enrolled in the ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the treatment of Huntington's disease.
- Lufax Holding Ltd (NYSE:LU) shares fell 3.7% to $2.86 in pre-market trading after gaining 17% on Tuesday.
- LegalZoom.com，Inc.（NASDAQ：LZ）股票在CEO變更和業績下調後的盤前交易中下跌18.3％，跌至6.41美元。
- Stardust Power股票（NASDAQ：SDST）在週二上漲約9％後，在盤前交易中下跌13.5％，跌至8.99美元。
- 10x genomics（NASDAQ：TXG）股票在盤前交易中下跌9.8％，跌至16.46美元。週二，高盛分析師Matthew Sykes維持10x Genomics賣出評級，並將目標價從26美元下調至16美元。
- IDEAYA Biosciences股票（NASDAQ：IDYA）在盤前交易中下跌6.4％，跌至36.13美元。IDEAYA定價2.63億美元向公衆發行228,572股普通股及預付權證，價格爲每股35美元。
- Hudson Pacific Properties股票（NYSE：HPP）在盤前交易中下跌4.9％，跌至4.90美元。
- uniQure N.V.股票（NASDAQ：QURE）在盤前交易中下跌4.5％，跌至6.37美元。週二，uniQure股票上漲76％，因公司宣佈包括29名接受AMt-130用於治療亨廷頓病的美國和歐洲I/II期臨床試驗的追蹤數據，包括長達24個月的追蹤數據。
- Lufax Holding Ltd（紐交所：LU）股票在週二上漲17％後，在盤前交易中下跌3.7％，跌至2.86美元。
Now Read This:
現在閱讀這個：
- Delta Air Lines Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
- 達美航空預計將發佈Q2季度收益下降的報告；以下是華爾街最準確分析師的最新預測變化。
譯文內容由第三人軟體翻譯。